from semaglutide to tirzepatide and treatment leads weight loss in type 1 diabetes Tirzepatide vs. Semaglutide: Key Differences

Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records

Abstract Purpose of Review This review explores the rationale and available evidence behind incretin-based therapies for metabolic dysfunction-associated steatotic disease (MASLD) and metabolic-associated steatohepatitis (MASH), focusing on glucagon-like peptide 1 (GLP-1) and glucagon (GCG) receptor dual agonists (GLP-1/GCG RAs)

Some patients notice improvements in hair quality and color

21 Lyxumia Summary of Product Characteristics